Trinity Biotech Market Cap 2006-2020 | TRIB

Trinity Biotech market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Trinity Biotech market cap as of July 01, 2020 is $0.05B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.051B $0.090B
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $162.097B 28.11
Medtronic (MDT) Ireland $123.829B 20.11
Stryker (SYK) United States $68.908B 22.36
Boston Scientific (BSX) United States $49.369B 23.21
Baxter (BAX) United States $44.284B 27.03
Lonza Group Ag (LZAGY) Switzerland $39.636B 0.00
Terumo (TRUMY) Japan $28.710B 36.70
EssilorLuxottica Societe Anonyme (ESLOY) France $28.492B 0.00
ResMed (RMD) United States $27.611B 43.58
Zimmer Biomet Holdings (ZBH) United States $24.632B 15.50
Smith & Nephew SNATS (SNN) United Kingdom $17.371B 0.00
Sunny Optical Technology (SNPTF) China $16.924B 0.00
Bio-Rad Laboratories (BIO) United States $13.472B 61.33
Insulet (PODD) United States $12.276B 1216.25
DiaSorin S.p.A (DSRLF) Italy $10.994B 0.00
Quidel (QDEL) United States $9.272B 72.86
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
Perrigo (PRGO) Ireland $7.474B 13.37
Hill-Rom Holdings (HRC) United States $7.352B 20.73
GN STORE NORD (GNNDY) Denmark $6.972B 35.54
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.778B 0.00
Haemonetics (HAE) United States $4.511B 27.09
Neogen (NEOG) United States $4.035B 68.35
GW Pharmaceuticals (GWPH) United Kingdom $3.918B 0.00
Agios Pharmaceuticals (AGIO) United States $3.833B 0.00
ICU Medical (ICUI) United States $3.803B 27.74
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.683B 0.00
Envista Holdings (NVST) United States $3.396B 0.00
NuVasive (NUVA) United States $2.910B 23.37
National Vision Holdings (EYE) United States $2.463B 42.61
TG Therapeutics (TGTX) United States $2.238B 0.00
AtriCure (ATRC) United States $1.814B 0.00
MacroGenics (MGNX) United States $1.419B 0.00
Aurora Cannabis (ACB) Canada $1.390B 0.00
Aphria (APHA) Canada $1.248B 0.00
NanoString Technologies (NSTG) United States $1.221B 0.00
Cerus (CERS) United States $1.109B 0.00
Cardiovascular Systems (CSII) United States $1.104B 0.00
Phibro Animal Health (PAHC) United States $1.052B 20.97
PetIQ (PETQ) United States $0.990B 28.61
Meridian Bioscience (VIVO) United States $0.977B 36.77
InMode (INMD) Israel $0.894B 18.90
Vapotherm (VAPO) United States $0.868B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.868B 144.46
Omeros (OMER) United States $0.818B 0.00
Zynex (ZYXI) United States $0.810B 81.37
Quanterix (QTRX) United States $0.787B 0.00
OraSure Technologies (OSUR) United States $0.698B 140.56
Eagle Pharmaceuticals (EGRX) United States $0.669B 47.94
VAREX IMAGING (VREX) United States $0.585B 14.52
Surmodics (SRDX) United States $0.584B 70.33
Lantheus Holdings (LNTH) United States $0.561B 11.28
LeMaitre Vascular (LMAT) United States $0.530B 30.16
Owens & Minor (OMI) United States $0.476B 12.60
BioLife Solutions (BLFS) United States $0.416B 145.82
Cytosorbents (CTSO) United States $0.361B 0.00
Repro-Med Systems (KRMD) United States $0.349B 289.00
Viemed Healthcare (VMD) United States $0.349B 30.97
Utah Medical Products (UTMD) United States $0.323B 23.48
HEXO (HEXO) $0.318B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.314B 0.00
Organigram Holdings (OGI) Canada $0.285B 0.00
Female Health (VERU) United States $0.228B 0.00
InfuSystems Holdings (INFU) United States $0.225B 124.56
Chimerix (CMRX) United States $0.198B 0.00
Surface Oncology (SURF) United States $0.185B 0.00
Evolus (EOLS) United States $0.182B 0.00
Bovie Medical (APYX) United States $0.181B 0.00
Exagen (XGN) United States $0.161B 0.00
Fonar (FONR) United States $0.136B 12.04
Rockwell Medical (RMTI) United States $0.134B 0.00
United Health Products (UEEC) United States $0.133B 0.00
Liberty Health Sciences (LHSIF) Canada $0.121B 0.00
MTech Acquisition (KERN) United States $0.115B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.103B 0.00
Wound Management Technologies (SMTI) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.081B 0.00
Nephros (NEPH) United States $0.073B 0.00
United-Guardian (UG) United States $0.068B 15.78
Capricor Therapeutics (CAPR) United States $0.067B 0.00
Chembio Diagnostics (CEMI) United States $0.066B 0.00
Brainsway (BWAY) Israel $0.065B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
GUARDION HEALTH (GHSI) United States $0.037B 0.00
FSD PHARMA INC (HUGE) Canada $0.028B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.013B 0.00
Myomo (MYO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00